1 enrolling by invitation, 1 terminated, 1 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Enrolling by invitation 1, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Terminated 1 |
Follow SBRT: new trials by email Literature Review of SBRT trials Research Report on SBRT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I Dose-escalation Trial of Definitive Single Dose Stereotactic Body Radiotherapy in Low-risk Breast Cancer Patients: DESERT I Trial SBRT level I, SBRT level II, SBRT level III - Breast Cancer Early Stage Breast Cancer (Stage 1-3), SBRT | Phase 1 | Enrolling by invitation | Universitat de les Illes Balears | 15 | 2024-09-27 | 2024-11-04 |
| Phase I/II Study of SBRT and GC4711 for Centrally Located or Large NSCLC GC4711 +SBRT, Placebo +SBRT - SBRT, NSCLC | Phase 1 / Phase 2 | Terminated | Galera Therapeutics, Inc. | 47 | 2020-10-18 | 2024-04-30 |
| Stereotactic Hypofractionated Accelerated Radiotherapy Post-Prostatectomy SBRT - Prostate Cancer Adenocarcinoma, Adjuvant Radiotherapy | Phase 1 | Unknown | Fundacao Champalimaud | 30 | 2016-11-01 | 2019-07-23 |
Breast Neoplasms (1)
Breast Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Fundacao Champalimaud (1) · Galera Therapeutics, Inc. (1) · Universitat de les Illes Balears (1)
Portugal (1) · Spain (1) · United States (1)
Carlo Greco, M.D. (1) · Eugene P Kennedy, MD (1) · Jon Gadea Quinteiro, Principal investigator (1)